This review systematically evaluates recent advances in lipid-based, polymeric, peptide, and exosome-derived nanocarriers, focusing on their design principles, mechanisms of uptake, and endosomal escape strategies, and highlights both the promise and the limitations of nanoparticle-mediated CRISPR/Cas9 RNP delivery.
V. Rajeshwar, Konda Ravi Kumar, Gollapalli Rajeev Kumar et al.· Current Gene Therapy· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.